IO Biotech, Inc. (IOBT): Price and Financial Metrics
IOBT Price/Volume Stats
| Current price | $1.43 | 52-week high | $1.73 |
| Prev. close | $1.50 | 52-week low | $0.66 |
| Day low | $1.20 | Volume | 244,552 |
| Day high | $1.50 | Avg. volume | 161,091 |
| 50-day MA | $1.11 | Dividend yield | N/A |
| 200-day MA | $1.02 | Market Cap | 94.21M |
IOBT Stock Price Chart Interactive Chart >
IO Biotech, Inc. (IOBT) Company Bio
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops disruptive immune modulating anti-cancer therapies in Denmark. The company's lead product candidate, IO102-IO103, is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death ligand (PD-L1). It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. IO Biotech, Inc. was incorporated in 2021 and is based in Copenhagen, Denmark.
IOBT Price Returns
| 1-mo | 45.92% |
| 3-mo | 62.72% |
| 6-mo | 76.54% |
| 1-year | 11.72% |
| 3-year | -62.27% |
| 5-year | N/A |
| YTD | 55.43% |
| 2024 | -51.06% |
| 2023 | -18.26% |
| 2022 | -64.06% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...